← FDA Drug Approvals (Drugs@FDA)

BUMETANIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MANKIND PHARMA · Approved 2025-04-03

Drug application

FDA Application #
ANDA219291
Application type
Abbreviated New Drug Application (Generic)
Brand name
BUMETANIDE
Generic name
BUMETANIDE
Active ingredients
BUMETANIDE
Dosage form
TABLET
Route
ORAL
Marketing status
Prescription
Sponsor
MANKIND PHARMA
Manufacturer
First Nation Group, LLC
First approval
2025-04-03

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown